WE HAVE waited a whole year for the watchdog Medicines and Healthcare products Regulatory Agency (MHRA) to update their Yellow Card covid vaccines ‘adverse events’ reporting (it once was monthly) though the booster programmes have rolled on regardless. The first new data since May 2024 has now been published. It takes us to May 13 of this year.
We commissioned our usual analysis, plus a special report on booster-related adverse events. Both make disturbing reading. The summaries below show that despite the government’s constant assurances, a further 218 fatalities have been recorded, bringing total UK covid vaccine fatalities to just under 3,000.
To date, 1 in 108 people injected have reported a ‘Yellow Card Adverse Event’ (assuming one person submits only one report) and 1 in 145 have reported a serious* event.
The latest data shows a further 10,181 people impacted over the last year, giving a new total of people impacted to nearly half a million. See below by vaccine type and manufacturer:
Pfizer/BioNTech-mono | 179,271 |
Pfizer/BioNTech-bivalent | 6,413 |
AstraZeneca | 250,356 |
Moderna-mono | 43,787 |
Moderna-bivalent | 6,042 |
Novavax | 275 |
Unknown brand | 3,528 |
Pfizer/BioNTech BA.4/5 – Spring 23 | 101 |
Pfizer/BioNTech XBB – Autumn 23 | 1,945 |
Pfizer/BioNTech JN.1 – Autumn 24 | 317 |
Moderna BA.4/5 – Spring 23 | 21 |
Moderna XBB – Autumn 23 | 2,687 |
Moderna JN.1 – Autumn 24 | 1,015 |
VidPrevtyn Beta – Spring 23 | 1,057 |
TOTAL REPORTS | 496,815 |
Frighteningly, of this number the vast majority (74.5 per cent) have been classified as serious* by the MHRA:
Pfizer/BioNTech-mono | 127,090 |
Pfizer/BioNTech-bivalent | 4,980 |
AstraZeneca | 194,172 |
Moderna-mono | 31,686 |
Moderna-bivalent | 4,438 |
Novavax | 161 |
Unknown brand | 2,541 |
Pfizer/BioNTech BA.4/5 – Spring 23 | 65 |
Pfizer/BioNTech XBB – Autumn 23 | 1,500 |
Pfizer/BioNTech JN.1 – Autumn 24 | 230 |
Moderna BA.4/5 – Spring 23 | 12 |
Moderna XBB – Autumn 23 | 1,946 |
Moderna JN.1 – Autumn 24 | 660 |
VidPrevtyn Beta – Spring 23 | 656 |
TOTAL Serious* Reports | 370,137 |
Worryingly, 48,083 (13 per cent) of these serious* reports are classified as people of ‘unknown age’. So we do not know how many children and young people may be among them.
Since some people report more than one type of reaction per report, the total number of reactions is much higher than the number of people who have been reported.
The total number of reactions recorded to date by the MHRA for each of the companies stands as follows:
Pfizer/BioNTech-mono | 518,998 |
Pfizer/BioNTech-bivalent | 17,633 |
AstraZeneca | 889,203 |
Moderna-mono | 143,835 |
Moderna-bivalent | 16,597 |
Novavax | 705 |
Unknown brand | 10,571 |
Pfizer/BioNTech BA.4/5 – Spring 23 | 414 |
Pfizer/BioNTech XBB – Autumn 23 | 5,300 |
Pfizer/BioNTech JN.1 – Autumn 24 | 868 |
Moderna BA.4/5 – Spring 23 | 48 |
Moderna XBB – Autumn 23 | 7,461 |
Moderna JN.1 – Autumn 24 | 2,724 |
VidPrevtyn Beta – Spring 23 | 2,765 |
TOTAL Reactions | 1,617,122 |
The last year has seen a further 218 fatalities – or ‘fatal’ reports – bringing the overall total covid vaccine fatalities to 2,925.
Pfizer/BioNTech-mono | 934 |
Pfizer/BioNTech-bivalent | 73 |
AstraZeneca | 1,520 |
Moderna-mono | 111 |
Moderna-bivalent | 57 |
Novavax | 0 |
Unknown brand | 112 |
Pfizer/BioNTech BA.4/5 – Spring 23 | 7 |
Pfizer/BioNTech XBB – Autumn 23 | 20 |
Pfizer/BioNTech JN.1 – Autumn 24 | 10 |
Moderna BA.4/5 – Spring 23 | 1 |
Moderna XBB – Autumn 23 | 27 |
Moderna JN.1 – Autumn 24 | 21 |
Vidprevtyn Beta – Spring 23 | 32 |
TOTAL FATAL REPORTS | 2,925 |
Inexplicably 485 (16.6 per cent) of the above fatalities are recorded as of ‘unknown age’ and at least 197 (6.7 per cent) are of ‘unknown sex’.
Disturbingly, too, overall now 1 in 169 reports are associated with a fatality, which may be less than 10 per cent of actual figures according to MHRA.
Since 2023 booster shotshave been offered only to eligible groups, officially described as vulnerable children and adults in clinical risk groups, including immunosuppressed and chronic health conditions, elderly in care homes and front-line healthcare workers (for some of the seasons).
In the last year 7,413 ‘booster only’ adverse event-related reports were submitted – 50 were for under-20-year-olds and 4,414 for 60 years and older:
Pfizer/BioNTech BA.4/5 – Spring 23 | 101 |
Pfizer/BioNTech XBB – Autumn 23 | 1,945 |
Pfizer/BioNTech JN.1 – Autumn 24 | 317 |
Moderna BA.4/5 – Spring ‘23 | 21 |
Moderna XBB – Autumn ‘23 | 2,687 |
Moderna JN.1 – Autumn ‘24 | 1,015 |
VidPrevtyn Beta – Spring ‘23 | 1,057 |
TOTAL BOOSTER RELATED REPORTS | 7,143 |
There were 118 fatal reports:
Pfizer/BioNTech BA.4/5 – Spring 23 | 7 |
Pfizer/BioNTech XBB – Autumn 23 | 20 |
Pfizer/BioNTech JN.1 – Autumn 24 | 10 |
Moderna BA.4/5 – Spring 23 | 1 |
Moderna XBB – Autumn 23 | 27 |
Moderna JN.1 – Autumn 24 | 21 |
VidPrevtyn Beta – Spring 23 | 32 |
TOTAL BOOSTER RELATED FATAL REPORTS | 118 |
One of the fatal reports involved an under-20-year-old; 103 reports
submitted were for 60 year and older.
In all there were 19,580 reactions (from the boosters only):
414 (Pfizer BA.4/5) + 48 (Moderna BA.4/5) + 5,300 (Pfizer XBB) + 7,461 (Moderna XBB) + 868 (Pfizer JN.1) + 2,724 (Moderna JN.1) + 2,765 (VidPrevtyn Beta).
The following horrifying catalogue of reaction types (more than one reaction may be included in one report) has been recorded:
General Disorders & Administration Site Conditions (incl. vaccination site issues, fever, fatigue, swelling, gait disturbances, pain, sudden death & flu-like illness): 104 (Pfizer BA.4/5) + 10 (Moderna BA.4/5) + 1,176 (Pfizer XBB) + 2,012 (Moderna XBB) + 175 (Pfizer JN.1) + 662 (Moderna JN.1) + 751 (VidPrevtyn Beta) = 4,890
Nervous System Disorders: 65 (Pfizer BA.4/5) + 8 (Moderna BA.4/5) + 883 (Pfizer XBB) + 1,308 (Moderna XBB) + 142 (Pfizer JN.1) + 503 (Moderna JN.1) + 406 (VidPrevtyn Beta) = 3,315
- Of which Strokes & CNS Haemorrhages: 6 (Pfizer BA.4/5) + 35 (Pfizer XBB) + 32 (Moderna XBB) + 6 (Pfizer JN.1) + 17 (Moderna JN.1) + 17 (VidPrevtyn Beta) = 113
- Headaches & Migraines:21 (Pfizer BA.4/5) + 3 (Moderna BA.4/5) + 250 (Pfizer XBB) + 476 (Moderna XBB) + 43 (Pfizer JN.1) + 174 (Moderna JN.1) + 145 (VidPrevtyn Beta) = 1,112
- Paralysis & Paresis:15 (Pfizer XBB) + 16 (Moderna XBB) + 1 (Pfizer JN.1) + 6 (Moderna JN.1) + 1 (VidPrevtyn Beta) = 39
- Tremor: 1 (Pfizer BA.4/5) + 1 (Moderna BA.4/5) + 32 (Pfizer XBB) + 75 (Moderna XBB) + 3 (Pfizer JN.1) + 21 (Moderna JN.1) + 16 (Vidprevtyn Beta) = 149
- Disturbance of Consciousness: 8 (Pfizer BA.4/5) + 1 (Moderna BA.4/5) + 95 (Pfizer XBB) + 162 (Moderna XBB) + 12 (Pfizer JN.1) + 59 (Moderna JN.1) + 45 (VidPrevtyn Beta) = 382
- Seizures:1 (Pfizer BA.4/5) + 19 (Pfizer XBB) + 22 (Moderna XBB) + 2 (Pfizer JN.1) + 14 (Moderna JN.1) + 7 (VidPrevtyn Beta) = 65
Musculoskeletal & Connective Tissue Disorders: 44 (Pfizer BA.4/5) + 7 (Moderna BA.4/5) + 580 (Pfizer XBB) + 881 (Moderna XBB) + 115 (Pfizer JN.1) + 326 (Moderna JN.1) + 320 (VidPrevtyn Beta) = 2,273
Diarrhoea, Nausea & Vomiting: 19 (Pfizer BA.4/5) + 1 (Moderna BA.4/5) + 264 (Pfizer XBB) + 555 (Moderna XBB) + 48 (Pfizer JN.1) + 204 (Moderna JN.1) + 208 (VidPrevtyn Beta) = 1,299
Infections & Infestations:12 (Pfizer BA.4/5) + 306 (Pfizer XBB) + 270 (Moderna XBB) + 53 (Pfizer JN.1) + 75 (Moderna JN.1) + 119 (VidPrevtyn Beta) = 835
Acute Cardiac Disorders:12 (Pfizer BA.4/5) + 3 (Moderna BA.4/5) + 346 (Pfizer XBB) + 242 (Moderna XBB) + 52 (Pfizer JN.1) + 86 (Moderna JN.1) + 63 (VidPrevtyn Beta) = 804
Eye Disorders:6 (Pfizer BA.4/5) + 84 (Pfizer XBB) + 96 (Moderna XBB) + 16 (Pfizer JN.1) + 45 (Moderna JN.1) + 33 (VidPrevtyn Beta) = 280
Tinnitus & Vertigo:1 (Pfizer BA.4/5) + 1 (Moderna BA.4/5) + 59 (Pfizer XBB) + 71 (Moderna XBB) + 11 (Pfizer JN.1) + 21 (Moderna JN.1) + 18 (VidPrevtyn Beta) = 182
Blood & Lymphatic Disorders: 5 (Pfizer BA.4/5) + 73 (Pfizer XBB) + 52 (Moderna XBB) + 9 (Pfizer JN.1) + 25 (Moderna JN.1) + 17 (VidPrevtyn Beta) = 181
Anaphylactic Responses: 1 (Pfizer BA.4/5) + 1 (Moderna BA.4/5) + 8 (Pfizer XBB) + 7 (Moderna XBB) + 2 (Moderna JN.1) + 5 (VidPrevtyn Beta) = 24
Injuries – Falls: 6 (Pfizer XBB) + 18 (Moderna XBB) + 6 (Moderna JN.1) + 1 (VidPrevtyn Beta) = 31
Neoplasms – Benign, Malignant & Unspecified: 1 (Pfizer BA.4/5) + 11 (Pfizer XBB) + 4 (Moderna XBB) + 6 (Pfizer JN.1) + 1 (Moderna JN.1) + 1 (VidPrevtyn Beta) = 24
Psychiatric Disorders:14 (Pfizer BA.4/5) + 1 (Moderna BA.4/5) + 151 (Pfizer XBB) + 190 (Moderna XBB) + 16 (Pfizer JN.1) + 73 (Moderna JN.1) + 57 (VidPrevtyn Beta) = 502
Renal & Urinary Disorders: 2 (Pfizer BA.4/5) + 1 (Moderna BA.4/5) + 32 (Pfizer XBB) + 45 (Moderna XBB) + 5 (Pfizer JN.1) + 16 (Moderna JN.1) + 15 (VidPrevtyn Beta) = 116
Reproductive/Breast Disorders: 73 (Pfizer XBB) + 40 (Moderna XBB) + 6 (Pfizer JN.1) + 21 (Moderna JN.1) + 3 (VidPrevtyn Beta) = 143
Respiratory Disorders:27 (Pfizer BA.4/5) + 4 (Moderna BA.4/5) + 307 (Pfizer XBB) + 374 (Moderna XBB) + 47 (Pfizer JN.1) + 142 (Moderna JN.1) + 222 (VidPrevtyn Beta) = 1,123
Skin Disorders:27 (Pfizer BA.4/5) + 2 (Moderna BA.4/5) + 361 (Pfizer XBB) + 513 (Moderna XBB) + 50 (Pfizer JN.1) + 214 (Moderna JN.1) + 226 (VidPrevtyn Beta) = 1,393
Vascular Disorders: 9 (Pfizer BA.4/5) + 1 (Moderna BA.4/5) + 98 (Pfizer XBB) + 128 (Moderna XBB) + 13 (Pfizer JN.1) + 58 (Moderna JN.1) + 51 (VidPrevtyn Beta) = 358
It is hard to understand why the British government is not following the advice of a number of senior doctors and specialists and withdrawing the covid vaccines altogether.
* The MHRA definition of ‘serious’: patient died, life threatening, hospitalisation, congenital abnormality, persistent or significant disability or capacity, deemed medically significant by MHRA medical dictionary or reporter.
For full reports see here.
Tomorrow I will be reporting on the equally shocking news, as insult is added to injury, that 88 per cent of people in the UK adversely affected by a Covid vaccine have been denied treatment by the NHS. These are the findings of a survey conducted by the charity, UKCVFamily.